Author Details - Journal of Thoracic Disease

Vol 5, No 4 (August 2013): Journal of Thoracic Disease - Editorial
Afatinib as first-line treatment for patients with advanced non-small-cell lung cancer harboring EGFR mutations: focus on LUX-Lung 3 and LUX-Lung 6 phase III trials
Abstract PDF Full Text
Vol 8, No 3 (March 2016): Journal of Thoracic Disease - Research Highlight
Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?
Abstract PDF Full Text
Vol 8, No 8 (August 2016): Journal of Thoracic Disease - Commentary
Proposals for revisions of the classification of lung cancers with multiple pulmonary sites: the radiologist’s, thoracic surgeon’s and oncologist’s point of view
Abstract PDF Full Text
Vol 9, Supplement 5 (May 2017): Journal of Thoracic Disease (EBUS-TBNA: Results and Perspective) - Review Article
Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspiration
Abstract PDF Full Text
Vol 12, No 7 (July 2020): Journal of Thoracic Disease - iMDT Corner
First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
Details PDF Full Text Reporting Checklist COI Form